Permeon Biologics
Cambridge
About Permeon Biologics
Permeon Biologics aims to enhance human health by using their novel Intraphilin Technology Platform™ to enable intracellular biologics as a revolutionary new generation of therapeutic drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $500K – $1M
- Total funding: $2.5M
- Last round: Series Unknown (Dec 2011)
- Website: permeonbio.com
- Phone: +1 617-945-7780
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/permeon-biologics-2710684 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.